{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:52:30Z","timestamp":1759146750474,"version":"3.40.5"},"reference-count":26,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,15]]},"DOI":"10.20945\/2359-3997000000316","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T16:07:07Z","timestamp":1608653227000},"source":"Crossref","is-referenced-by-count":2,"title":["An intricate case of sporadic pseudohypoparathyroidism type 1B with a review of literature"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1981-5982","authenticated-orcid":false,"given":"Jos\u00e9 Diogo Ramalho e","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-6390","authenticated-orcid":false,"given":"Gustavo Filipe Melo Alves","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9546-3347","authenticated-orcid":false,"given":"Maria Jo\u00e3o Martins","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"key":"key20201222110659_B1","first-page":"922","article-title":"Pseudohypoparathyroidism: an example of Seabright-Bantam syndrome","volume":"30","author":"Albright","year":"1942","unstructured":"1. Albright F, Burnett C, Smith P, Parson W. Pseudohypoparathyroidism: an example of Seabright-Bantam syndrome. Endocrinology. 1942;30:922-32.","journal-title":"Endocrinology"},{"issue":"6","key":"key20201222110659_B2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/cen.12948","article-title":"Pseudohypoparathyroidism \u2013 epidemiology, mortality and risk of complications","volume":"84","author":"Underbjerg","year":"2016","unstructured":"2. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Pseudohypoparathyroidism \u2013 epidemiology, mortality and risk of complications. Clin Endocrinol (Oxf). 2016;84(6):904-11.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key20201222110659_B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2188\/jea.10.29","article-title":"Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan","volume":"10","author":"Nakamura","year":"2000","unstructured":"3. Nakamura Y, Matsumoto T, Tamakoshi A, Kawamura T, Seino Y, Kasuga M, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol. 2000;10(1):29-33.","journal-title":"J Epidemiol"},{"issue":"4","key":"key20201222110659_B4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MOP.0000000000000783","article-title":"Management of pseudohypoparathyroidism","volume":"31","author":"Germain-Lee","year":"2019","unstructured":"4. Germain-Lee EL. Management of pseudohypoparathyroidism. Curr Opin Pediatr. 2019;31(4):537-49.","journal-title":"Curr Opin Pediatr"},{"issue":"10","key":"key20201222110659_B5","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1210\/jc.2015-4310","article-title":"The Prevalence of GNAS Deficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network","volume":"101","author":"Elli","year":"2016","unstructured":"5. Elli FM, Linglart A, Garin I, de Sanctis L, Bordogna P, Grybek V, et al. The Prevalence of GNAS Deficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network. J Clin Endocrinol Metab. 2016;101(10):3657-68.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20201222110659_B6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.22696","article-title":"GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders","volume":"36","author":"Lemos","year":"2015","unstructured":"6. Lemos MC, Thakker RV. GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders. Hum Mutat. 2015;36(1):11-9.","journal-title":"Hum Mutat"},{"issue":"6","key":"key20201222110659_B7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MED.0b013e32835a255c","article-title":"An update on the clinical and molecular characteristics of pseudohypoparathyroidism","volume":"19","author":"Levine","year":"2012","unstructured":"7. Levine MA. An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes. 2012;19(6):443-51.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"8","key":"key20201222110659_B8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement","volume":"14","author":"Mantovani","year":"2018","unstructured":"8. Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol. 2018;14(8):476-500.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"key20201222110659_B9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15592294.2016.1264561","article-title":"Recommendations for a nomenclature system for reporting methylation aberrations in imprinted domains","volume":"13","author":"Monk","year":"2018","unstructured":"9. Monk D, Morales J, den Dunnen JT, Russo S, Court F, Prawitt D, et al. Recommendations for a nomenclature system for reporting methylation aberrations in imprinted domains. Epigenetics. 2018;13(2):117-21.","journal-title":"Epigenetics"},{"issue":"4","key":"key20201222110659_B10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000355384","article-title":"The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene","volume":"80","author":"Turan","year":"2013","unstructured":"10. Turan S, Bastepe M. The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene. Horm Res Paediatr. 2013;80(4):229-41.","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"key20201222110659_B11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jbmr.2408","article-title":"TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib)","volume":"30","author":"Molinaro","year":"2015","unstructured":"11. Molinaro A, Tiosano D, Takatani R, Chrysis D, Russell W, Koscielniak N, et al. TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib). J Bone Miner Res. 2015;30(5):906-12.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"key20201222110659_B12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/hmg\/ddi009","article-title":"Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB","volume":"14","author":"Liu","year":"2005","unstructured":"12. Liu J, Nealon JG, Weinstein LS. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet. 2005;14(1):95-102.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"key20201222110659_B13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI10431","article-title":"A GNAS1 imprinting defect in pseudohypoparathyroidism type IB","volume":"106","author":"Liu","year":"2000","unstructured":"13. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest. 2000;106(9):1167-74.","journal-title":"J Clin Invest"},{"issue":"4","key":"key20201222110659_B14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40618-016-0588-4","article-title":"Pseudohypoparathyroidism: one gene, several syndromes","volume":"40","author":"Tafaj","year":"2017","unstructured":"14. Tafaj O, Juppner H. Pseudohypoparathyroidism: one gene, several syndromes. J Endocrinol Invest. 2017;40(4):347-56.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"key20201222110659_B15","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1210\/jc.2012-1655","article-title":"Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B","volume":"97","author":"Neary","year":"2012","unstructured":"15. Neary NM, El-Maouche D, Hopkins R, Libutti SK, Moses AM, Weinstein LS. Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B. J Clin Endocrinol Metab. 2012;97(9):3025-30.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20201222110659_B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2015.05.011","article-title":"Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B)","volume":"79","author":"Takatani","year":"2015","unstructured":"16. Takatani R, Minagawa M, Molinaro A, Reyes M, Kinoshita K, Takatani T, et al. Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B). Bone. 2015;79:15-20.","journal-title":"Bone"},{"issue":"8","key":"key20201222110659_B17","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/jbmr.408","article-title":"Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib?","volume":"26","author":"Fernandez-Rebollo","year":"2011","unstructured":"17. Fernandez-Rebollo E, Perez de Nanclares G, Lecumberri B, Turan S, Anda E, Perez-Nanclares G, et al. Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib? J Bone Miner Res. 2011;26(8):1854-63.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"key20201222110659_B18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/epi.09.11","article-title":"Environmental signals and transgenerational epigenetics","volume":"1","author":"Skinner","year":"2009","unstructured":"18. Skinner MK, Guerrero-Bosagna C. Environmental signals and transgenerational epigenetics. Epigenomics. 2009;1(1):111-7.","journal-title":"Epigenomics"},{"issue":"9","key":"key20201222110659_B19","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1210\/jc.2007-0869","article-title":"Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib","volume":"92","author":"Mantovani","year":"2007","unstructured":"19. Mantovani G, Bondioni S, Linglart A, Maghnie M, Cisternino M, Corbetta S, et al. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab. 2007;92(9):3738-42.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20201222110659_B20","doi-asserted-by":"crossref","first-page":"E2314","DOI":"10.1210\/jc.2012-2920","article-title":"De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases","volume":"97","author":"Turan","year":"2012","unstructured":"20. Turan S, Ignatius J, Moilanen JS, Kuismin O, Stewart H, Mann NP, et al. De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases. J Clin Endocrinol Metab. 2012;97(12):E2314-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20201222110659_B21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1210\/jc.2009-0176","article-title":"Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients","volume":"95","author":"Mantovani","year":"2010","unstructured":"21. Mantovani G, de Sanctis L, Barbieri AM, Elli FM, Bollati V, Vaira V, et al. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab. 2010;95(2):651-8.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20201222110659_B22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2169\/internalmedicine.53.0459","article-title":"A 22-year-old woman with hypocalcemia and clinical features of albright hereditary osteodystrophy diagnosed with sporadic pseudohypoparathyroidism type Ib using a methylation-specific multiplex ligation-dependent probe amplification assay","volume":"53","author":"Zeniya","year":"2014","unstructured":"22. Zeniya S, Yuno A, Watanabe T, Usui T, Moriki Y, Uno Y, et al. A 22-year-old woman with hypocalcemia and clinical features of albright hereditary osteodystrophy diagnosed with sporadic pseudohypoparathyroidism type Ib using a methylation-specific multiplex ligation-dependent probe amplification assay. Intern Med. 2014;53(9):979-86.","journal-title":"Intern Med"},{"issue":"6","key":"key20201222110659_B23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrendo.2016.52","article-title":"Pseudohypoparathyroidism and Gsalpha-cAMP-linked disorders: current view and open issues","volume":"12","author":"Mantovani","year":"2016","unstructured":"23. Mantovani G, Spada A, Elli FM. Pseudohypoparathyroidism and Gsalpha-cAMP-linked disorders: current view and open issues. Nat Rev Endocrinol. 2016;12(6):347-56.","journal-title":"Nat Rev Endocrinol"},{"issue":"23","key":"key20201222110659_B24","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa1012717","article-title":"Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance","volume":"364","author":"Linglart","year":"2011","unstructured":"24. Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, Cancel M, et al. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med. 2011;364(23):2218-26.","journal-title":"N Engl J Med"},{"issue":"10","key":"key20201222110659_B25","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1210\/jc.2011-1048","article-title":"Clinical review: Pseudohypoparathyroidism: diagnosis and treatment","volume":"96","author":"Mantovani","year":"2011","unstructured":"25. Mantovani G. Clinical review: Pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab. 2011;96(10):3020-30.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20201222110659_B26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3360","article-title":"Bone mineral density and its serial changes are associated with PTH levels in pseudohypoparathyroidism type 1B patients","volume":"33","author":"Chu","year":"2018","unstructured":"26. Chu X, Zhu Y, Wang O, Nie M, Quan T, Xue Y, et al. Bone mineral density and its serial changes are associated with PTH levels in pseudohypoparathyroidism type 1B patients. J Bone Miner Res. 2018;33(4):743-52.","journal-title":"J Bone Miner Res"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T16:07:23Z","timestamp":1608653243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020005010204&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":26,"alternative-id":["10.20945\/2359-3997000000316"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000316","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}